Global Access To Cell And Gene Therapy: ARM Studios Interview With Boro Dropulić

What Will It Take to Expand Global Access to Cell and Gene Therapies? At the 2024 Cell & Gene Meeting on the Mesa, ARM’s Stephen Majors sat down with Boro Dropulić, CEO of Caring Cross, for an insightful conversation at ARM Studios. Together, they explored the critical challenges and opportunities in making advanced therapies more accessible worldwide — from innovative manufacturing models to sustainable pricing strategies and equitable distribution. Don’t miss this compelling interview on how the cell and gene therapy sector can turn scientific breakthroughs into global health solutions.